June 4, 2026 · Form 4 insider transaction
POST LEONARD E bought 1,000 shares of CG Oncology, Inc. at $0.60 per share, a transaction worth $600.00. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026